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ABSTRACT 
Large  synaptosome  fractions  were  isolated  from  the  cerebellar  and  cerebral 
cortices of rats and were incubated with Clostridium botulinum type A  neurotoxin 
in vitro. The binding of the neurotoxin to the synapses was observed by electron 
microscopy, using the double-sandwich immunocytochemical method. Botulinum 
neurotoxin  was preferentially bound  to  the  presynaptic membrane in  the  large 
synaptosome fraction. The binding regions for the neurotoxin were localized on 
both the extrajunctional and junctional areas of the presynaptic membranes and 
appeared  as  patches  of  various  sizes.  However,  they  did  not  exist  on  the 
postsynaptic  membranes.  Botulinum  neurotoxin  is  proposed  to  be  a  useful 
analytical tool for understanding the characteristics of the presynaptic membranes 
in the central nervous system. 
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Synapses have two main functions:  one is chemical 
transmission and the other is recognition of part- 
ner cells with which to establish synaptic contact 
during  developmental  processes.  The  molecular 
mechanisms of both impulse transformation and 
neuronal recognition are not well known to date. 
To understand  these  phenomena, it is necessary 
to clarify the  structural  organization of the  syn- 
apses, especially that of the pre- and postsynaptic 
membranes. 
Numerous investigations have been carried out 
to characterize the structure of the synaptic mem- 
branes by electron microscope observations with 
various kinds of techniques (I, 3,  13).  Another 
approach to this goal is to use specific compounds 
such  as  t~-bungarotoxin  (22)  and  lectins  which 
bind to membrane components in a specific man- 
ner (2, 7,  19).  We have examined the structure 
and  function  of  the  synapses  with  the  use  of 
neurotoxins such as Clostridium botulinum  neuro- 
toxin (17, 21) and fl-bungarotoxin (14-16). 
CI. botulinum  toxin is well known, on the basis 
of physiological  and pharmacological studies (4-6, 
8,  12,  18,  23,  26,  27,  28),  to block transmitter 
release at neuromuscular junctions.  The toxin is 
thought to act at neuromuscular junctions so as to 
reduce the influx of Ca ions into the nerve termi- 
nal or to decrease the efficiency of intracellular Ca 
ions  in  eliciting  transmitter release,  or both  (8, 
12). Binding of the toxin at neuromuscular junc- 
tions has been visualized by fluorescence micros- 
copy  (29)  and  autoradiography  of  l~I-labeled 
botulinum toxin (17). Recent studies have shown 
that CI. botulinum  type A  neurotoxin was bound 
to  the  synaptosome fractions  (10,  11,  21)  and 
synaptosomal plasma membranes (21) from brain 
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43 homogenates  and  also  that  transmitter  release 
from  cerebral  synaptosomes was  affected  by  the 
toxin  (28).  However,  it is still unknown whether 
the  binding  sites  for  the  toxin  are  located  pre- 
and/or postsynaptically. 
In  the  present  study,  we  have  intended  to 
visualize by means of electron microscope immu- 
nocytochemistry  the  binding region for Cl.  botu- 
linum  type A  neurotoxin on the synaptic fraction 
prepared from rat central nervous tissue. 
MATERIALS  AND  METHODS 
Preparation of the Neurotoxin from Cl. 
botulinum  Type A  Crystalline Toxin 
The botulinum type A  crystalline toxin was supplied 
by Dr.  E. J. Schantz (Wisconsin University). The neu- 
rotoxin,  a  toxic  subunit  (c~-fraction)  of  the  type  A 
crystalline  toxin  of  150,000  mol  wt  (9),  was  isolated 
from the crystalline toxin by diethyaminoethyl (DEAE)- 
Sephadex chromatography (20) and dialyzed against 10 
mM phosphate buffer, pH 7.2, containing 0.15 M NaC1 
(phosphate-buffered saline [PBS]). The neurotoxin was 
homogeneous by disc electrophoresis and immuno-dif- 
fusion tests (Fig. 1). 
Preparation o  fan Antiserum Directed 
against the Neurotoxin of Cl. 
botulinum  Type A 
The  neurotoxin  was  mixed  with  0.4%  formalin  to 
obtain a  protein concentration of 100  jzg/ml,  and the 
mixture was incubated for 4  d  at 37~  to prepare  the 
toxoid.  It was then emulsified with an equal volume of 
Freund's complete  adjuvant  (Difco  Laboratories,  De- 
troit, Mich.),  and 4  ml of the toxoid-adjuvant mixture 
FIGURE  1  Agar gel  diffusion test between botulinum 
neurotoxin and  anti-botulinum neurotoxin rabbit IgG. 
The  central  well  contained botulinum  neurotoxin,  70 
/xg/ml  10 mM PBS, pH 7.2, and outer wells contained 
anti-botulinum neurotoxin rabbit IgG, 6.1  mg/ml PBS. 
One precipitation line was observed between central and 
outer wells. 
was injected subcutaneously into two rabbits. The sec- 
ond immunization was carried out with the toxoid after 
1 too. The antiserum was collected after 2 wk. The IgG 
fraction was purified from the sera by gel filtration on 
Sephadex G  200.  The  prepared  anti-neurotoxin rabbit 
IgG (anti-neurotoxin-IgG) neutralized the muscle-para- 
lyzing effect of the neurotoxin in mice. The botulinum 
neurotoxin and the anti-neurotoxin rabbit IgG prepara- 
tion  formed  a  single precipitation line  in  an  agar gel 
diffusion test (Fig. 1). The ferritin-conjugated anti-rabbit 
IgG goat IgG (anti-IgG-Fe) was purchased from Miles 
Yada Ltd. (Kiryat, Weizmann, Israel). 
Preparation of Large 
Synaptosome Fractions 
Large  synaptosomes were prepared according to the 
modified procedure of Kelly et al. (19). After decapita- 
tion, the cerebellum and cerebrum of adult rats were cut 
into slices  ~2  mm thick, and the cerebellar cortex and 
cerebral  cortex  of  the  parietal  lobe  were  dissected. 
About 190 mg wet weight of each tissue preparation was 
homogenized in 4  ml of 0.32 M  sucrose at 0~  1 mM 
phosphate  buffer,  pH  7.2,  containing  1  mM  MgCI 
(SPB),  by  10  manual  passes  in  a  tight-fitting Dounce 
homogenizer  (Kontes Co.,  Vineland, N.  J.).  The  ho- 
mogenate was centrifuged at 2,000 g  for 4  min at 4~ 
and the pellet was resuspended in SPB at a final concen- 
tration of 7-8 mg protein/ml. 
lmmunocytochemistry 
Three  kinds of experiments were  carried out under 
different conditions. 
E  XP I:  0.2 ml of a suspension of large synaptosomes 
was  incubated with  0.04  ml  of botulinum neurotoxin 
(1,660,000 LD~0/ml and 99  /xg protein/ml) at 37~  for 
30 min. The reacted mixture was centrifuged at 9,950 g 
for 2  min, and then the pellet was washed three times 
with SPB by centrifugation. For toxicity determinations, 
0.1 ml of the supernate from the first centrifugation was 
taken out, diluted with 0.5 ml of PBS, and 0.1 ml of the 
diluted supernates was injected into each mouse.  Each 
supernate was injected into four mice to determine the 
toxicity (Table I). The pellet suspended in 0.1 ml of SPB 
was reacted with 0.1  ml on anti-neurotoxin rabbit IgG 
(6.1 mg protein/ml) for 1 h at 37~  After washing, the 
pellets were suspended in 0.2 ml of anti-IgG-Fe (5.6 mg 
protein/ml) for 1 h at 37~ 
For the control studies, the large synaptosomes were 
incubated with either one of the following: (a) 0.04 ml 
of only SPB;  (b)  0.04  ml  of the  toxoid  (100  /xg/ml) 
which was denatured by formalin to prepare the antise- 
rum against botulinum neurotoxin; (c) 0.04 ml of natu- 
rally denatured toxin (100  /.tg/ml)  which was obtained 
by  storing  at  4~  for  2  mo,  and  were  subsequently 
treated as mentioned above. 
EXP  lI"  0.2  ml of the suspension of large  synapto- 
somes was incubated with 0.04 ml of botulinum neuro- 
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fuged at 9,950 g  for 2 rain,  and the pellet was washed 
three times with SPB  and reacted with 0.1  ml of anti- 
neurotoxin  IgG  (6.1  mg protein/ml) for  16  h  at 4~ 
After washing  at  4~  three  times,  the  pellet was  sus- 
pended in 0.2  ml of anti-IgG-Fe and  kept for 12  h  at 
4~ 
Three  kinds  of control  studies  were  carded  out  as 
described above. 
EXP  In:  0.2 ml of each suspension  of large synap- 
tosomes was  fixed with 0.1%  formaldehyde in  0.1  M 
cacodylate  buffer,  pH  7.4,  for  15  min  at  20~  The 
suspension  was centrifuged at 9,950g for 2 rain, and the 
pellet was washed three times with SPB and resuspended 
in 0.2  ml of SPB. Then the suspension  was  incubated 
with  0.04  ml  of neurotoxin  at  37~  for  30  rain  and 
washed three times with SPB. The washed sample was 
reacted with anti-neurotoxin IgG at 37~  for 1 h. After 
washing, it was suspended in anti-IgG-Fe at 37~  for 1 
h. 
The  prefixed  sample  was  incubated  with  the  three 
kinds of solutions used in exp I for control studies  and 
processed as mentioned above. 
For the electron microscope observations, the speci- 
mens were prepared  as follows:  The reaction mixtures 
from exp I  and  exp III were washed  three  times with 
SPB  and  fixed  in 2.5%  glutaraldehyde,  2% formalde- 
hyde in  0.1  M  cacodylate buffer,  pH  7.4,  for 3  h  at 
20~  The  samples  of exp  II were  fixed  in  the  same 
fixative at 4~  for 4 h. All the samples were posffixed in 
2% OsO4  in 0.1  M cacodylate buffer for 1.5  h at 4~ 
and were resuspended  in a small volume of warm 4% 
(wt/vol) agar. 
The agar gel was cut into small pieces, stained en bloc 
in 1% uranyl acetate in Kellenberger's buffer overnight, 
dehydrated  in graded alcohols, and embedded in Aral- 
dite. Ultrathin sections were cut with an LKB ultratome 
(LKB Instruments,  Inc., Rockville, Md.),  stained with 
uranyl  acetate  and  lead  citrate,  and  examined  in  a 
Hitachi 12A electron microscope. 
RESULTS 
It  was  demonstrated,  by  measuring  the  toxicity 
remaining in the supernate after incubation of the 
reaction  mixture,  that  the  botulinum  neurotoxin 
binds to the large synaptosomes.  More than 99% 
of  the  neurotoxin  is  bound  when  incubated  at 
37~  with large synaptosome fractions of cerebral 
and cerebellar cortices (Table I). However, it does 
not bind  at 0~  and  only a  small amount  of the 
toxin binds to synaptosomes at 4~ 
Morphologically, the large synaptosome  prepa- 
rations  from  cerebellar  cortex were  observed  to 
contain synaptosomes of various sizes (Figs. 2 and 
4),  while the  synaptosomes  from cerebral cortex 
were of relatively uniform size. 
TABLE I 
Toxicity of  the Incubation Media 
Before incubation 
After incubation with cerebral 
cortex 
After incubation with cerebel- 
lar cortex 






EXP  I"  The  localization  of  binding  sites  for 
Cl.  botulinum  neurotoxin  is  observed  as  neuro- 
toxin, anti-neurotoxin IgG, and anti-IgG-Fe com- 
plexes (BoTX-IgG-anti-IgG-Fe) at the surface of 
the  synaptosomes  prepared  from  cerebral  and 
cerebellar cortices (Figs. 2, 3, and 5). The BoTX- 
IgG-anti-IgG-Fe  complexes  are  localized  as 
patches of various sizes on presynaptic membranes 
(Figs.  2,  3,  and  5).  The  processes  identified  as 
presynaptic  are  filled with  clear vesicles,  coated 
vesicles, and mitochondria and often show presyn- 
aptic  membrane  specializations  (Figs.  2  and  5). 
BoTX-IgG-anti-IgG-Fe  complexes  are  located 
widely  on  extrajunctional  membranes  when  the 
presynaptic processes are attached to the postsyn- 
aptic processes (Figs. 2  and 5). When the presyn- 
aptic and  postsynaptic processes are partially dis- 
sociated,  the  BoTX-IgG-anti-IgG-Fe  complexes 
are  often  found  in  the  cleft  regions  of partially 
opened  synapses  as  well  as  at  extrajunctional 
membranes of presynaptic processes (see Fig. 6). 
The immune complexes are sometimes found as a 
single aggregate on part of the presynaptic mem- 
brane; most commonly, however, they are distrib- 
uted as multiple patches of various sizes over the 
entire  surface of the presynaptic  endings  (Figs. 2 
and  5).  The  BoTX-IgG-anti-IgG-Fe  complexes 
are  not  observed  on  the  plasma  membrane  of 
either  free  or  attached  postsynaptic  processes 
(Figs. 2 and 5), which are identified as the profiles 
that show postsynaptic membrane thickenings and 
do not contain vesicles, nor are they found on the 
membrane of glial cells. 
EXP  lI:  The  immune  complexes  are  always 
observed  as  multiple  patches  of various  sizes  all 
around the circumference of the presynaptic mem- 
branes;  they  never  occur  as  a  single  aggregate. 
The complexes also  appear  in the cleft region of 
partially opened  synapses  (Fig.  6),  whereas  they 
are not located on postsynaptic  membranes  (Fig. 
6). 
EXP  IlI:  The  results  are essentially similar to 
those obtained in exp II. 
HmorawA  AND  KrrAMURA Binding  of Clostridium botulinum Neurotoxin  45 lq6URE  2  A  large presynaptic process (PR)  attached to several postsynaptic processes (PO) prepared 
as described for exp I at 37~  BoTX-IgG-anti-IgG-Fe complexes occur on the presynaptic membrane as 
patches (arrows). Note that the complexes are not present on the postsynaptic membranes. Bar, 1 /zm. x 
35,700. 
~CURE  3  An enlarged view of the upper left part of Fig. 2. The immune complexes are observed on the 
presynaptic membrane. Bar, 0.1  /xm. ￿  90,000. FIGURE 4  A Control sample prepared as in exp I and incubated with the toxoid. A presynaptic process 
(PR) with postsynaptic  processes (PO) in the cerebellar cortex.  BoTX-IgG-anti-IgG-Fe  Complexes are 
not found on the presynaptic membrane or in any other area. Bar, 0.1 gm. ￿  43,400. 
In  the  control experiments of Exp.  I,  II, and 
III,  no  BoTX-IgG-anti-IgG-Fe complexes occur 
on the synaptic membranes (Fig. 4). 
DISCUSSION 
The  present study demonstrates that the binding 
sites for CI. botulinum  neurotoxin do exist widely 
on the presynaptic membranes of the cerebral and 
cerebeUar cortices, but do not occur on postsyn- 
aptic membranes nor on membranes of glial origin 
in  the  large  synaptosome  preparations  isolated 
from rat brain homogenates. 
The immune complexes are not found in typical 
synaptic clefts when the presynaptic processes are 
not  dissociated from  the  postsynaptic processes, 
while they occur in the clefts of partially opened 
synapses in all the samples. However, they have 
never  been  observed on  free  postsynaptic proc- 
esses which  show  postsynaptic membrane  thick- 
enings. The possibility  exists that the double-sand- 
wich immunocytochemical method may not allow 
for  the  anti-neurotoxin  IgG  or  anti-IgG-Fe  to 
infiltrate the narrow synaptic clefts. So, the bind- 
ing  sites  for  the  botulinum  neurotoxin  may  be 
localized to the junctional region as well. In exp I 
the immune complexes are sometimes observed as 
a  single patch on  the  surface of the  presynaptic 
endings; this phenomenon,  however,  is not seen 
in  exp  II  and  III.  This  result  may  be  due  to 
membrane  fluidity (24,  25),  because  the  move- 
ment of the  membrane molecules in exp. II and 
III may be inhibited as compared with exp. I. As 
a  result,  the  immune  complexes  are  found  as 
multiple patches of various sizes over the entire 
surface of the presynaptic membrane in exp. I, II, 
and III. The patching process observed in exp. I, 
II, and III may be  due  to some extent to cross- 
linking of the binding sites by the divalent ligands 
(24). 
From these results, we conclude that the bind- 
ing  sites for  botulinum  neurotoxin  are  localized 
widely on the presynaptic membranes of cerebral 
and cerebellar cortices but not on the postsynaptic 
membranes. The results of the present study are 
HmOKAWA AND  KrrAMURA Binding  of Clostridium botulinum Neurotoxin  47 FIGURE  5  A  presynaptic process (PR) and  postsynaptic process (PO) from  the  cerebellar  cortex 
prepared  as  described  for  exp  I  at  37~  BoTX-IgG-anti-IgG-Fe complexes occur  widely  on  the 
presynaptic membrane, but the complexes are not present in the narrow synaptic cleft. Small arrowheads: 
postsynaptic membrane thickening. Large arrowhead: active zone. Bar, 0.1  ~m. x  80,200. 
Ftt~URE  6  A  presynaptic  process (PR) and  postsynaptic process (PO) from  the  cerebellar cortex 
prepared as described for exp II at 4~  BoTX-IgG-anti-IgG-Fe complexes are found as patches all over 
the presynaptic membranes and at the cleft region (arrow). Small  arrowheads: postsynaptic membrane 
thickening. Large arrowheads: active zone. Bar, 0.1  /.tm. ￿  94,300. 
48  THE  JOURNAL OF  CELL BIOLOGY" VOLUME 81, 1979 at variance with those obtained with lectins, be- 
cause  the  binding sites for lectins exist on both 
pre- and postsynaptic membranes (2, 7,  19).  So 
far,  the  receptor  for the  botulinum toxin is  the 
first  molecule  by  which  the  membrane  of  the 
presynaptic processes  can be  distinguished from 
that  of  the  postsynaptic  processes  in  terms  of 
binding properties. 
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